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Impairment of non-muscle myosin IIA in human CD41 T
cells contributes to functional deficits in the elderly
Stefania Cane1, Subramaniam Ponnappan2 and Usha Ponnappan1,2
Physiological aging imposes significant alterations in the repertoire of T cells and all associated functions. Although several studies
have reported defects upon antigen-induced activation of T cells during aging, the molecular mechanisms that control T-cell receptor
(TCR) downmodulation remain to be fully defined. While previous studies have assessed the role of F-actin in regulating
activation-induced TCR internalization, few have delineated the roles of motor proteins, such as non-muscle myosin IIA (NMMIIA). In
this study, we describe a series of experiments supporting the hypothesis that effective TCR downmodulation requires not only efficient
reorganization of the actin cytoskeleton, but also functional NMMIIA. For the first time, we show that CD41 T cells from elderly human
donors have dysfunctional NMMIIA that contributes to delaying activation-induced TCR internalization and impairing calcium
mobilization. Additionally, our results demonstrate that chemical inhibition of NMMIIA in CD41 T cells from young donors also results
in complete abrogation of TCR internalization, strongly supporting the fundamental role of NMMIIA in modulating this event. Recent
observations that the generation of an efficient T-cell response requires migration prompted us to investigate whether NMMIIA also
plays a regulatory role in CD41 T-cellmigration.We show that chemical inhibition ofNMMIIA downmodulates chemotacticmigration in
CD41 T cells fromboth young and elderly donors. Together, these data demonstrate a significant contribution of dysfunctional NMMIIA
to TCR-mediated functional defects during aging.
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INTRODUCTION
Aging is a complex process that is accompanied by a decline in various
physiological processes.1 In particular, the immune senescence that
often accompanies aging of the immune system is characterized by
alterations in both innate and adaptive immunity, as well as by the
occurrence of chronic inflammatory processes.2–4 The increased
incidence and severity of infectious diseases in the elderly population
and their reduced ability to mount an appropriate immune response
upon immunization 5,6 correlate well with relatively weak and non-
specific CD41 T-cell activation, resulting in a dramatic decrease in the
efficacy of responses to vaccination in the elderly.6 Clinically, this is
important because the elderly are highly encouraged to get vaccinated
for infectious diseases such as influenza and pneumococcal pneu-
monia.1,5 On the one hand, minimal alterations in the total number
of CD41T cells have been noted with age, but on the other, substantial
alterations in their signal transduction,3 proliferative responses and
migration7–9 have been documented in murine models. Elegant stud-
ies employing a mouse model for aging have shown that CD41 T cells
from aged T-cell receptor (TCR)-transgenic mice fail to form efficient
immunological synapses (IS) with antigen-presenting cells (APCs), as
seen in CD41 T cells from young mice.10 Additionally, these data
demonstrate that aging in mice leads to decreased recruitment of
TCR-associated proteins, such as Lck, Vav and Moesin/Ezrin, to the
IS.9,11 The recruitment of signaling molecules in CD41 T cells from
older mice is approximately 50% of that observed in the young
cohorts. Furthermore, CD41T cells from agedmice exhibit significant
changes in cytoskeletal rearrangement, irrespective of the activation
status, which leads to alteration in TCR-rich contact zones and T-cell
trafficking.12 Although the role of microcluster formation in the ini-
tiation of T-cell activation is well established in both murine models
and cell lines, the molecular mechanisms that underlie termination
of T-cell activation, such as TCR internalization13 in primary human
T cells, remain poorly defined.
The initial contact of CD41 T cells with APCs14–17 leads to a series of
cytoskeleton reorganizations, including the molecular segregation of T-
cell signaling molecules, polymerization and depolymerization of F-
actin,16 and development of lamellipodia,18,19 as posited by the kinetic
segregation model of T-cell activation.20,21 These events, which are
tightly controlled in terms of the duration and strength of the response,
are followed by termination events, primarily consisting of downmodu-
lation of cell surface TCR expression due to a combination of increased
internalization, decreased recycling and increased degradation.
Emerging studies,22–24 primarily employing cancer cells, have
demonstrated the fundamental role of heat shock protein 90
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(Hsp90) in regulating microtubules and intermediate filaments of
the cytoskeleton.25–27 However, limited information is available on
the role of Hsp90 in cell morphology and migration of T cells and
in activation-dependent early events. We therefore assessed the
contribution of Hsp90 in early events of T-cell activation and
termination.
The data generated previously from our laboratory clearly dem-
onstrate that aging is accompanied by a decline in both the amount
and function of Hsp90, whichmay contribute to the inability of CD41
T cells from elderly humans to undergo activation-induced prolifera-
tion or secrete IL-2. Given that key tyrosine kinases involved in T-cell
signaling are Hsp90 client proteins,27 we were interested in determin-
ing whether immune senescence impacted the pattern of Hsp90-inter-
acting proteins in CD41 T cells. We now show that non-muscle
myosin IIA (NMMIIA),28–30 a motor protein composed of six poly-
peptide chains, is differentially co-precipitated with Hsp90 in lysates
obtained fromCD41 T cells from elderly and young donors. NMMIIA
is composed of two identical heavy chains (myosin IIA), two essential
light chains and two regulatory light chains (RLC or myosin light
chain (MLC)). Activation of NMMIIA requires the phosphorylation
of Thr18 and Ser19 residues on the RLCs primarily by calcium kinase
and Rho-associated coiled coil-containing kinase. In the context of T-
cell biology, recent work by Dustin and colleagues28 clearly demon-
strated that phosphorylation of RLCs is necessary for the proper
assembly of the T-cell signalosome and for the stability of the IS.
Given the emerging role of NMMIIA in regulating many aspects of
T-cell biology, we now provide evidence that outlines the contribution
of NMMIIA to the observed defects in primary human CD41 T cells
during aging. Our results for the first time demonstrate that altered
functional NMMIIA occurs in T cells from the elderly and this altera-
tion in NMMIIA may contribute to defects in early signaling events,
including calciummobilization, TCR internalization and chemotactic
migration toward stromal cell-derived factor (SDF)-1a.
MATERIALS AND METHODS
Antibodies and reagents
Antibodies to myosin IIA, MLC2 and MLC2 phosphorylated at Ser19
were from Cell Signaling Technology (Danvers, MA, USA).
Antibodies to Hsp90, TCR-a/-b chains and horseradish peroxidase-
conjugated goat anti-mouse were from BD Biosciences (San Jose, CA,
USA). The b-actin antibody was from Santa Cruz biotechnology
(Santa Cruz, CA, USA). Alexa Fluor 488-conjugated mouse anti-rab-
bit and Alexa Fluor 555-conjugated goat anti-mouse secondary anti-
bodies and Fura-2AM were from Invitrogen (Carlsbad, CA, USA).
Mouse anti-human CD3 was purified from an OKT3 hybridoma
supernatant. Horseradish peroxidase-conjugated goat anti-rabbit
immonoglobulin was from Thermo Fisher Scientific (Rockford, IL,
USA). All fine chemicals were obtained from Sigma-Aldrich (Saint
Louis, MO, USA), unless otherwise mentioned. Rhodamine-phalloi-
din was obtained from Cytoskeleton (Denver, CO, USA). SDF-1a was
from ProSpec-Tany Technogene (Rehovot, Israel). The electrophor-
esis supplies were from Bio-Rad (Hercules, CA, USA).
Human subjects
Peripheral blood was obtained by venipuncture from healthy young
(21–30 years) and elderly (65–89 years) adults enrolled from the
greater Little Rock area. Immunocompromised subjects were
excluded from the study, including individuals with asthma and those
taking immune-modulating drugs. Subjects on antibiotics orwith self-
reported symptoms of recent infection (,3 weeks before enrollment)
were also excluded. All protocols involving human subjects were
approved by the University of Arkansas for Medical Sciences
(UAMS) Institutional Review Board, and the appropriate informed
consents were obtained. Blood was drawn at the Clinical Research
Center at UAMS. The demographics of the volunteers recruited for
the study were as follows: the young donor population consisted of
62%males and 38% females with an average age of 25.5 years. Of these
individuals, 86%were Caucasians, 10%Asians and the rest minorities.
The elderly donor population consisted of 43% males and 57%
females with an average age of 75 years, and 93% of these individuals
were Caucasians, with the rest minorities.
T-lymphocyte isolation
CD41 T cells were negatively selected from blood using the EasySep
CD41 T-cell Enrichment Kit according to the manufacturer’s recom-
mended protocol (StemCell Tech, Vancouver, Canada). The purity of
isolated CD41 T cells was determined by flow cytometry and was
consistently 90%–95%. Lymphocytes were isolated from peripheral
blood mononuclear cells following Ficoll/Hypaque-gradient centrifu-
gation of whole blood. In our young donor population, T cells repre-
sented 80%–82% of peripheral blood mononuclear cells, with an
average of 85% being CD41 T cells. In the elderly group, T cells
represented 81%–83% of peripheral blood mononuclear cells,
with 84% being CD41 T cells. Of the CD41 T lymphocytes,
CD45RA1CCR71CD45RO2 cells represented an average of 54%,
and CD45RO1CD45RA2 represented an average of 46% in young
donors. These were 48% and 52%, respectively, in the elderly donor
group. T regulatory cells, identified as CD41FOXP31CD251 cells,
represented a mean of 4.82% of the CD4 population in the young
donors and a mean of 5.87% of the CD4 population in the elderly
donors.
Flow cytometry
For surface staining, CD41 T cells were incubated with antibody
directed to TCR-a/-b (BD Biosciences) followed by incubation with
an antibody conjugated to Alexa Fluor 555 for 20 min at 4 uC. At the
end of incubation, cells were washedwith ice-cold phosphate-buffered
saline (PBS) containing 0.1% bovine serum albumin (BSA) and fixed
with 2% paraformaldehyde. For intracellular staining of F-actin, cells
were fixed (2% paraformaldehyde), permeabilized (PBS buffer10.1%
saponin) and stained with rhodamine-phalloidin based on the man-
ufacturer’s protocol (Cytoskeleton).
Quantitative PCR with reverse transcription
Total RNA was isolated using TRIzol Reagent (Invitrogen). Briefly,
4 mg of total RNA for each sample was reverse transcribed, and the
resultant cDNA was amplified using a Bio-Rad iCycler PCR system.
Reactions were performed in 96-well PCR plates using 12.5 ml of iQ
SYBR Green Supermix (Bio-Rad), forward and reverse primers
(0.3 nmol each), and cDNA (3 ml) in a final volume of 25 ml.
Amplification parameters were denatured at 95 uC for 10 min fol-
lowed by 40 cycles at 95 uC for 30 s and 60 uC for 70 s. Samples
were analyzed in duplicate for the expression of NMMIIA, and
human b-actin and GAPDH were used as normalization genes.
Fold induction was calculated after normalization using the
DDCT method. The dissociation curves indicated that each reaction
consisted of a single reaction product. Gene-specific primers were
designed by Primer3 software employing human sequences
obtained from GenBank. The primer sequences will be provided
upon request.
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Confocal microscopy
Freshly isolated CD41 T cells were stained for TCR-a/-b (BD
Biosciences) according to the manufacturer’s protocol. Briefly, cells
were incubated with antibody directed to TCR-a/-b for 20 min and
followed by an anti-rabbit Alexa Fluor 555. The cells were then washed
and fixed with 2% paraformaldehyde, prior to mounting on poly-
L-lysine-coated coverslips. For intracellular protein staining of
NMMIIA, CD41 T cells were fixed, permeabilized (PBS buffer10.1%
saponin), and stained with anti-myosin IIA antibody. Anti-rabbit
Alexa Fluor 488 was used as the detection reagent. A series of fluor-
escence images were captured by a Zeiss confocal LSM 510 META
(Carl Zeiss, Thornwood, NY, USA) using a Plan-Apochromat 63/1.4
oil differential interference contrast objective. The images were pro-
cessed and analyzed with LSM510 and ImageJ software.
Calcium imaging
Intracellular calcium concentrations were measured with the cal-
cium indicator dye Fura-2AM. CD41 T cells were stimulated with
Staphylococcus enterotoxin A-loaded Raji B cells (10 ng/ml) or ionomy-
cin (50 ng/ml). Briefly, CD41 T cells were loaded with the dye by
incubation with 5 mM of Fura-2AM at 37 uC for 30 min in complete
media, followed by a 30-min chase. Imaging was performed with an
InCa dual-wavelength system (Intracellular Imaging, Cincinnati, OH,
USA) with the calcium concentration calculated as the relationship
between the ratio of emission at 505 nm to excitation at 340 and
380 nm. Each experimental data point represents the average of calcium
concentration calculated from at least 20 individually measured CD41
T cells from three different fields and six independent donor pairs.
Chemotactic migration assay
CD41 T cells (33105) either left untreated or pre-treated with bleb-
bistatin (50 mM, 1 h) were resuspended in 100 ml of medium contain-
ing 0.2% BSA and placed into the upper chamber of a transwell
migration plate (5 mmpores; Costar, Corning, NY, USA). In the lower
chamber, 600 ml of media containing 0.2% BSA with or without
100 nM of SDF-1a was added, and cells were allowed to migrate for
4 h at 37 uC. The number of migrated cells was counted following
Trypan blue staining. The percent of migrating cells and migration
index were derived from these data.
Western blotting and co-immunoprecipitation
CD41 T-cell lysates, equalized for protein levels, were resolved using
sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–
PAGE), transferred to nitrocellulose membranes, immunoblotted
with specific antibody(s) and detected using chemiluminescence.
For co-immunoprecipitation studies, precleared total cell lysates
(250 mg protein) were incubated with an antibody to Hsp90 and pro-
tein A/G agarose beads overnight at 4 uC with gentle rocking. Protein
A/G beads containing the adsorbed immunoprecipitated complex
were washed with radio immunoprecipitation assay buffer, resus-
pended in 30 ml of 2X SDS sample buffer and heated in a boiling water
bath for 5 min. Protein complexes were resolved by SDS–PAGE and
subjected to western blot analyses, as detailed above.
Liquid chromatography–tandem mass spectrometry (LC–MS/MS)
methods
Protein bands following SDS–PAGE, were excised and subjected to in-
gel trypsin digestion as follows. Protein-containing gel slices were
destained in 50% methanol, then 100 mM ammonium bicarbonate,
followed by reduction in 10 mM Tris(2-carboxyethyl)phosphine and
alkylation in 50 mM iodoacetamide. The gel slices were then dehy-
drated in acetonitrile, followed by the addition of 100 ng sequencing-
grade porcine trypsin in 100 mM ammonium bicarbonate (Sigma-
Aldrich) and incubated at 37 uC for 12–16 h. The peptide products
were then acidified in 0.1% formic acid. Tryptic peptides were sepa-
rated by reverse-phase high-performance liquid chromatography on a
10-cmC18 column using a NanoLC 2D system (Eksigent, Dublin, CA,
USA) and ionized by electrospray upon elution, followed by MS/MS
analysis using an LTQ XL mass spectrometer (Thermo Scientific,
Waltham, MA, USA). Proteins were identified from MS/MS spectra
by database searching using theMascot search engine (Matrix Science,
Boston, MA, USA).
F-actin polymerization assay
Briefly, primary CD41 T cells were either left untreated or activated
with plate-bound aCD3 for 2, 5 or 10min. At the end of treatment, the
cells were subjected to intracellular staining using rhodamine-phalloi-
din as per the manufacturer’s protocol, employing flow cytometry.
The data were analyzed using CellQuest Pro software (BD Biosciences).
Statistical analyses
Differences between the means were analyzed using Student’s t-tests,
and differences were considered significant if P,0.05.
RESULTS
NMMIIA is an abundant protein that coprecipitates with Hsp90 in
CD41 T cells from elderly donors
As immune senescence is accompanied by lowered levels and reduced
chaperone activity of Hsp90 in T cells,1 we were interested in profiling
and identifying Hsp90-associated proteins in T cells during aging.
Previous studies employing murine T cells have demonstrated signifi-
cant changes in the ratio of memory to naive T cells with advancing
age, with a preponderance of the memory population. Therefore, we
initiated analyses of naive and memory subsets in our T-cell pools.
However, our studies employing flow cytometry demonstrated only a
minimal increase in memory population with advancing age. In fact,
CD41CD45RO1 memory T cells, negatively selected using specific
antibodies against CD8, CD14, CD16, CD19, CD20, CD36, CD56,
CD123, TCR-c/-d, glycophorin A and CD45RA, were present at levels
similar to those observed in samples from young donors.We therefore
used the entire population of CD41T cells in our assays to evaluate the
impact of aging. We initially immunoprecipitated Hsp90 from CD41
T-cell lysates obtained from young and elderly donors and resolved
them using SDS–PAGE, followed by staining with Bio-Safe
Coomassie. One of the abundant proteins obtained following immu-
noprecipitation derived from CD41 T cells from elderly donors,
appearing at 225 kDa (Figure 1a), was excised and subjected to in-
gel trypsin digestion. Tryptic peptides were subjected to LC–MS/MS
analysis, and proteins were identified fromMS/MS spectra by database
searching using the Mascot search engine.
As shown in Figure 1b, the protein band detected in lysates from the
elderly (resolving at approximately 225 kDa) was identified as
NMMIIA. Approximately 412 unique peptides were identified that
matched with NMMIIA. From a total of 311 spectra, 180 were unique
to the matched protein. Overall, these peptides covered 58% of the
full-length NMMIIA protein. The presence of NMMIIA was further
confirmed by immunoprecipitation followed by immunoblotting
(data not shown). While this is the first demonstration of abun-
dant NMMIIA in Hsp90 immunoprecipitates from CD41 T cells
from elderly donors, NMMIIA has previously been identified in
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immunoprecipitates of Hsp90 and as an Hsp90-binding partner in
proteomic studies in other cell types, such as fibroblasts.31
NMMIIA, a motor protein, is a member of the non-muscle motor
protein family and plays vital roles in cell polarization, migration,
adhesion and cytokinesis.18,20,28
NMMIIA expression remains unaltered in CD41 T cells during
aging
Given the observation that increased association of NMMIIA with Hsp90
occurs in T cells obtained from elderly donors when compared to those
from young donors, we next assessed both the constitutive and induced
protein levels and mRNA expression of NMMIIA in CD41 T cells
obtained from both young and elderly donors. CD41 T cells were either
left untreated or treated with plate-bound anti-CD3 antibody for 10 min.
At the end of the incubation, cells were lysed, and approximately 25 mg of
proteins was resolved by SDS–PAGE followed by western blotting with
antibody to NMMIIA. As shown in Figure 2a and b, we observed a subtle
but consistent increase in constitutive NMMIIA protein expression in
CD41 T cells from elderly donors when compared with those from
young donors. Additionally, treatment with anti-CD3 failed to induce
any further change in the expression of NMMIIA above constitutive
levels in cells from both young and old donors. Interestingly, while the
reactivity of NMMIIA with the antibody resulted in distinct bands at
about 250 kDa in the lysates of CD41 T cells from young donors, in
contrast, CD41 T-cell lysates obtained from the elderly demonstrated
significant reactivity with several lower molecular weight proteins, which
was further accentuated following anti-CD3 treatment. While it is not
clear whether these were degradation products or lower molecular weight
isoforms, preliminary studies employing phospho-myosin IIA (data not
shown) appear to indicate folding intermediates. Future studies will
determine the precise nature of these intermediates and the underlying
basis for these anti-myosin IIA-reactive bands in cells from the elderly.
It is important to note that NMMIIB was not detected in primary CD41
T cells from young or elderly donors.
To determine whether alterations in the transcription of NMMIIA
occur with age, we next examined the mRNA expression of NMMIIA
by quantitative PCR with reverse transcription in CD41 T cells from
young and elderly human donors. The results presented in Figure 2c
demonstrate that NMMIIAmRNA expression level in CD41 T cells was
not affected by the age of the donor. Employing Jurkat T cells and
actinomycin D, we next evaluated the half-life of NMMIIA mRNA.
Our results indicated a relatively high stability of NMMIIA mRNA,
Figure 1 Hsp90-associated proteins detected by co-immunoprecipitation in CD41T-cell lysates from the elderly. (a) Hsp90 co-immunoprecipitated proteins obtained
from CD41 T cells from five independent young and elderly donor pairs were resolved by SDS–PAGE and stained with Bio-Safe Coomassie. The predominant band at
225 kDa (more abundent in the elderly) was excised and analyzed by LC–MS/MS. (b) Proteomic profiles (spectrum and amino acid sequence) of peptides that
matched the myosin IIA protein sequence obtained from the excised band. Hsp90, heat shock protein 90; LC–MS/MS, liquid chromatography–tandem mass
spectrometry; SDS–PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis.
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with a turnover rate longer than 72 h (data not shown). Thus, the
increased association of NMMIIA with Hsp90 observed upon immu-
noprecipitation in CD41 T cells from the elderly could not be attributed
to an overall increase in protein or mRNA expression of NMMIIA.
Myosin RLC is constitutively phosphorylated in CD41 T cells
obtained from elderly donors
As recent studies have demonstrated a critical role for the phos-
phorylation of RLCs in the assembly of T-cell signalosome21,28
during the initiation of T-cell signaling,13,18,32 we next analyzed the
phosphorylation status of RLC inCD41T cells from young and elderly
donors, prior to and following activation with immobilized anti-CD3
for 10 min. The cell lysates resolved by SDS–PAGE were immuno-
blotted using antibodies specific to RLC and phosphorylated RLC
(pRLC). As shown in Figure 3, overall levels of RLC were similar in
CD41 T cells obtained from young and elderly donors, prior to and
following activation with anti-CD3. In contrast, pRLC was detected
only upon treatment with anti-CD3 in CD41 T cells from young
donors, while they were already detectable under basal conditions in
lysates obtained from the elderly. Activation with anti-CD3 resulted in
no further increase in pRLC in cells from the elderly. Thus, RLC
appears to be constitutively phosphorylated in CD41 T cells from
elderly donors and is unaffected by treatment with anti-CD3. To
our knowledge, this is the first report of altered activation of
NMMIIA in CD41 T cells from the elderly. As pRLC is important in
T-cell signaling, our data for the first time demonstrate altered regu-
lation of pRLC in CD41 T cells from the elderly, and we believe that
this may underlie some of the reported defects in T-cell activation
during aging.
Altered distribution of NMMIIA but not TCR-a/-b in T cells
accompanies aging
IS are initiated by signaling in discrete TCR microclusters, and
these microclusters play an important role in T-cell functional differ-
entiation and effector functions.18,33,34 Furthermore, microcluster
movement and assembly are associated with centripetal actin flow in
coordination with NMMIIA activation.20,21,35 The importance of
NMMIIA in T-cell signaling and inherent alterations in NMMIIA
activation status during aging prompted us to study the cellular local-
ization of NMMIIA in CD41 T cells from young and elderly donors
Figure 2 Expression of non-muscle myosin IIA in CD41 T cells from young and
elderly donors. (a) Western blot of NMMIIA in CD41 T cells from young and
elderly donors either left untreated or activated with anti-CD3 beads for 10 min.
b-actin was used as a control for equal protein loading. Representative data from
one donor pair out of eight pairs tested are provided. (b) The specific band for
myosin IIA protein was quantified by densitometry. The values represent the
mean integrated density6s.e. obtained from a minimum of eight independent
donor pairs. (c) qRT-PCR analysis of myosin IIA mRNA from total RNA collected
from CD41 T cells. The average data from 10 donor pairs are provided. b-actin
and GAPDH were used as reference genes and for normalization. The data are
presented as fold induction. GAPDH, glyceraldehyde-3-phosphate dehydrogen-
ase; NMMIIA, non-muscle myosin IIA; qRT-PCR, quantitative PCR with reverse
transcription.
Figure 3 Constitutively activated NMMIIA is detected in T cells from the elderly.
(a) Western blot of MLC2 and pMLC2 in CD41 T cells from young and elderly
donors either left untreated or activated with anti-CD3 beads for 10 min. b-actin
was used as a control for equal loading. Representative data from one donor pair
out of eight pairs tested are provided. (b) The specific band for pMLC2 protein
was quantified by densitometry. The values represent the mean integrated den-
sity6s.e. obtained from aminimum of eight independent donor pairs. ** denotes
statistical significance at P,0.001. MLC, myosin light chain; NMMIIA, non-mus-
cle myosin IIA; pMLC, phosphorylated myosin light chain.
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employing confocal microscopy. The CD41 T cells from young and
elderly donors were either left untreated or pre-treated with blebbis-
tatin, a NMMIIA-specific inhibitor. The CD41 T cells were then
stained with an antibody to either NMMIIA or TCR-a/-b, followed
by the appropriate fluorescent secondary antibody. As shown in
Figure 4, NMMIIA appeared to be strongly associated with the plasma
membrane in CD41 T cells from the young donors. However, in
CD41 T cells from the elderly, NMMIIA showed a more diffuse and
punctate cytosolic localization, with minimal membrane localization.
Interestingly, pre-treatment of the cells with blebbistatin induced a
punctate/diffuse distribution of NMMIIA in CD41T cells from young
donors, mimicking the distribution seen constitutively in CD41 T
cells from elderly donors (Figure 4). As blebbistatin is a chemical
inhibitor of functional NMMIIA activity, it appears that inhibition
of NMMIIA results in the loss of plasma membrane localization of
NMMIIA, as seen in T cells from the elderly. This altered NMMIIA
localization was in clear contrast to the pattern of TCR locali-
zation observed in CD41 T cells, which was predominantly
localized to the plasma membrane both under basal and blebbista-
tin-treated conditions, regardless of the age of the T-cell donor
(Figure 5). Thus, our findings demonstrate that inhibition of
NMMIIA by blebbistatin results in punctate, cytosolic rather than
plasma membrane distribution of NMMIIA in CD41 T cells from
young donors, mimicking the observation in untreated CD41 T cells
from the elderly, with little or no impact on the cell surface distri-
bution of TCR-a/-b.
Nonfunctional NMMIIA negatively impacts F-actin polymerization
in CD41 T cells
One of the earliest events during CD41 T-cell activation is the rapid
and transient conversion of monomeric actin, G-actin, into filament-
ous actin, F-actin. Actin and NMMIIA interact,33 and the actomyosin
complex plays an important role not only in the modification of cell
shape, but also in crawling and migration in T cells. Although defects
in F-actin polymerization have been reported in T cells from murine
models of aging,9 limited data exist with regard to actin dynamics in
activated human T cells during aging, and the role of NMMIIA in this
process remains unknown. Consequently, employing primary CD41
T cells obtained from young and elderly donors, we evaluated the
changes in F-actin polymerization during anti-CD3-induced activa-
tion. As shown in Figure 6a, anti-CD3 treatment of CD41 T cells
induced an increase in F-actin that was significantly more pronounced
in CD41 T cells obtained from the young than the elderly donors. In
addition, we also observed a significant age-related difference in the
kinetics of F-actin polymerization. Specifically, in CD41 T cells from
young donors, the levels of F-actin peaked as early as 2 min and
decreased gradually, returning to near basal levels by 10 min of anti-
CD3 activation. However, in CD41 T cells from elderly donors, the
levels of F-actin did not change significantly frombaseline, irrespective
of the time of anti-CD3 activation, indicating a defect in activation-
induced F-actin polymerization. To determine if the observed defect
in F-actin polymerization is due to nonfunctional NMMIIA, we pre-
treated CD41 T cells with blebbistatin and subsequently activated the
cells with anti-CD3 for 2, 5 or 10min. As shown in Figure 6b, chemical
inhibition of NMMIIA resulted in partial inhibition of F-actin poly-
merization, which wasmore pronounced in the CD41 T cells obtained
from young donors than those from the elderly. Thus, we conclude
that functional inhibition of NMMIIA negatively impacts
F-actin polymerization, which may potentially underlie the inability
of T cells from the elderly to mediate early cytoskeletal events, includ-
ing microcluster formation in the initiation of T-cell activation and
TCR internalization in the termination of activation.
Figure 4 Localization and distribution of myosin IIA in CD41 T cells from young
and elderly donors. (a) Confocal microscopy of myosin IIA distribution in CD41 T
cells from young and elderly donors that were either left untreated (vehicle con-
trol) or pre-treated with blebbistatin. Representative data from one donor pair out
of a minimum of 10 pairs tested are provided. (b) Cumulative data of intracellular
myosin IIA fluorescence intensity in CD41 T cells from 10 independent donor
pairs. Themean fluorescence intensity ofmyosin IIA localized on the inner face of
the plasma membrane is provided. Quantification of the fluorescence signal of
myosin IIA in the inner face of the plasma membrane was performed on the
complete three-dimensional confocal stack for 30 cells obtained from each of
five different fields from aminimumof 10 independent experiments. The data are
represented as the mean plasma membrane-associated fluorescence intensi-
ty6s.e. ** denotes statistical significance at P,0.001.
Figure 5 Cell surface TCR-a/-b expression in CD41 T cells is not affected by age.
Confocal microscopy of TCR-a/-b expression in CD41 T cells from young and
elderly donors that were either left untreated (vehicle control) or pre-treated with
blebbistatin. Representative data are from one donor pair out of 10 pairs tested.
The fluorescence intensity of TCR-a/-b in the plasma membrane was performed
on the complete three-dimensional confocal stack for 30 cells obtained from a
minimum of five different fields each, from aminimum of 10 independent experi-
ments. TCR, T-cell receptor.
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Functional NMMIIA is necessary for activation-induced
internalization of TCR-a/-b
T-cell activation by a cognate antigen or anti-CD3 antibody results in
the rapid internalization of TCR molecules, resulting in fewer TCR
molecules at the surface.13,17,36 This downmodulation of the TCR–
CD3 complex plays an important role in fine-tuning the avidity and
strength of major histocompatibility complex–TCR interaction, and
in attenuating TCR signaling. Although recent reports clearly dem-
onstrate a role for NMMIIA in microcluster migration and the
stability of the IS, a role for NMMIIA in mediating internalization
of TCR-a/-b and receptor downmodulation has not been investigated.
Consequently, to elucidate the role of NMMIIA on the internalization
of TCR-a/-b receptors, we performed flow cytometry on CD41 T cells
from young and elderly donors, before and after treatment with anti-
CD3, for defined periods of time, in the presence and absence of
blebbistatin. As shown in Figure 7, the surface expression of TCR-
a/-b receptors was similar in untreated T cells from young and elderly
donors, demonstrating no change in TCR expression with the age of
the donor population. Upon treatment with immobilized anti-CD3,
CD41 T cells from young donors demonstrated a rapid decrease in the
surface expression of TCR-a/-b as early as 10 min, accounting for
approximately 60% loss in expression, which reached 80% by
40 min, indicating internalization. In contrast, CD41 T cells from
elderly donors demonstrated decreased internalization, with an aver-
age 30% decrease in TCR-a/-b surface expression at 10 min following
treatment with anti-CD3, approaching a 50% maximum decrease in
expression even after 40 min of treatment. To evaluate the contri-
bution of functional activity of NMMIIA during this process, we next
pre-treated CD41 T cells from young and elderly donors with bleb-
bistatin and then either left the cells untreated or activated them with
immobilized anti-CD3 antibody for 10 or 40 min. Our results
(Figures 7 and 8) demonstrate that treatment with blebbistatin per
se does not impact the basal level of TCR-a/-b expression, irrespective
of the age of the T-cell donor. However, treatment with blebbistatin
significantly inhibited anti-CD3-mediated internalization of TCR-a/-
b receptors at both 10 and 40 min in CD41 T cells obtained from
young donors, resulting in an average internalization of approxi-
mately 20% at 10 min and 30% at 40 min. In contrast, cells from
the elderly failed to show a significant decline upon treatment with
blebbistatin (Figures 7 and 8). Based on these results, we conclude that
inhibition of the functional activity of NMMIIA negatively impacts
anti-CD3-mediated TCR-a/-b internalization/downmodulation and
hence cell surface expression in CD41 T cells from young donors, thus
mimicking the overall phenotype observed in anti-CD3-activated but
blebbistatin-untreated CD41 T cells from the elderly.
NMMIIA negatively regulates intracellular calcium release upon
TCR engagement in CD41 T cells
In CD41 T cells, calcium ions (Ca21) function as critical second
messengers. Calcium signals regulate the activation of lymphocytes,
their differentiation and multiple effector functions, as well as the
induction of a variety of transcriptional programs.13 In lymphocytes,
sustained calcium entry is necessary for complete activation of
calcineurin-dependent nuclear factor of activated T-cell pathways.
Immune senescence is accompanied by a reduction in calcium release
Figure 6 Anti-CD3-induced F-actin polymerization in CD41 T cells during aging.
(a) CD41 T cells were either left untreated or activated with plate-bound anti-CD3
for 2, 5 or 10 min. At the end of activation, cells were fixed, stained with rhoda-
mine phalloidin and analyzed by flow cytometry. The data represent the
mean6s.e. derived from 10 independent donor pairs. (b) CD41 T cells were
either pre-treated with blebbistatin or vehicle control, then activated with plate-
bound anti-CD3 for 2, 5 or 10min. F-actin polymerization was determined by flow
cytometry. The data represent the mean6s.e. obtained from 10 independent
donor pairs. * denotes statistical significance at P,0.05.
Figure 7 Activation-induced internalization of TCR-a/-b is delayed in CD41 T
cells from elderly donors. CD41 T cells obtained from young and elderly donors
were either left untreated or activated with 5 mg/well plate-bound anti-CD3 for 10
or 40 min. The cells were then stained using antibody to TCR-a/-b, followed by
Alexa Fluor 555-conjugated secondary antibody, and then fixed with 2% PFA.
Representative data are from one donor pair out of five pairs tested. Surface
expression of TCR was detected by flow cytometry. Representative data from
one donor pair are depicted in the histogram. Cumulative data obtained from a
minimum of five independent donor pairs are provided. PFA, paraformaldehyde;
TCR, T-cell receptor.
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from intracellular stores upon lymphocyte activation. Because a defect
in TCR-a/-b internalization was observed in CD41 T cells from the
elderly and upon pre-treatment with blebbistatin inCD41T cells from
young donors, we next evaluated the impact of inhibition of NMMIIA
on activation-induced calcium release from intracellular stores. CD41
T cells obtained from both young and elderly donors were either pre-
treated with blebbistatin or left untreated and subsequently incubated
with superantigen-pulsed APCs at a ratio of 1 : 1 (Raji B cells pulsed
with Staphylococcus enterotoxinA).Microfluorescent imaging of intra-
cellular calcium influx was monitored by loading CD41 T cells with
Fura-2AM. As previously reported in murine studies, our results con-
firm that CD41 T cells obtained from elderly human donors, activated
by incubation with pulsed APCs, demonstrated lower and sustained
calcium release from intracellular stores when compared with simi-
larly treated cells from young donors (Figure 9), where the levels of
calcium demonstrated a rapid, significant peak response. Pre-treat-
ment of CD41 T cells with blebbistatin completely abrogated the
release of intracellular calcium upon TCR-a/-b engagement by anti-
gen-pulsed APCs, irrespective of the age of the donor. Interestingly,
blebbistatin treatment failed to impact ionomycin-mediated calcium
release from CD41 T cells from both young and elderly donors,
implicating a role for NMMIIA function in early events of TCR-a/-
b signaling. Thus, a fully functional NMMIIA appears to be an active
and necessary participant in calcium release from intracellular stores
following TCR engagement, underscoring its role in regulating key
steps in early signaling events activated by effective TCR engagement.
Chemotactic migration of CD41 T cells in response to SDF-1a is
enhanced in CD41 T cells from the elderly
Continuous recirculation of CD41 T cells and their eventual migra-
tion to tissues upon activation is important for protective immunity
against invading pathogens.37,38 In migrating cells, actin organizes
into two basic structures, the lamellipodium and the uropod.
Functional NMMIIA is required not only in the generation of the
driving force, but also in actomyosin complex formation and F-actin
polymerization.20,21 Therefore, we evaluated the role of NMMIIA in
chemotactic migration during aging. Migration39,40 was evaluated by
employing a chemotactic gradient of human SDF (hSDF)-1a. CD41 T
cells from young and elderly donors were allowed to migrate for 4 h in
transwell plates that were either left uncoated (PBS–BSA) or coated
with 100 nM of hSDF-1a. As shown in Figure 10a, CD41 T cells from
both young and elderly donors migrated minimally in the absence of
hSDF-1a. However, in response to hSDF-1a, CD41 T cells from both
young and elderly donors demonstrated robust migration. Significantly
higher numbers of CD41 T cells from elderly donors migrated toward
hSDF-1a than those from young donors. This observation is in agree-
ment with data previously reported for CD41 splenic T cells in aged
mice, where an increase in the percentage of transmigration was
Figure 8 Inhibition of NMMIIA results in delayed internalization of cell surface TCR-a/-b. (a, c) CD41 T cells obtained from young and elderly donors were either left
untreated or pre-treated with blebbistatin, then activated with 5 mg/well plate-bound anti-CD3 for 10 or 40min. The cells were then stained using an antibody to TCR-a/
-b, followed by Alexa Fluor 555-conjugated secondary antibody, and fixed with 2% PFA. Surface expression of TCR was detected by flow cytometry. Representative
data from one donor pair are shown. (b, d), Cumulative data from aminimum of five independent pairs of young and elderly donors. The percentage of internalization
was calculated based on the mean fluorescence intensity. The data represent the mean fluorescence intensity6s.e. ** denotes statistical significance at P,0.001.
NMMIIA, non-muscle myosin IIA; PFA, paraformaldehyde; TCR, T-cell receptor.
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reported in response to SDF-1a.41 Additionally, increased CXCR4
expression has been demonstrated in T cells from mice during
aging, which may account for the increased migration towards
hSDF-1a,41 observed in our samples. Inhibition of NMMIIA activ-
ity by pre-treatment with blebbistatin resulted in a profound
inhibition of the migration toward hSDF-1a in CD41 T cells from
both young and elderly donors (Figure 10b). Taken together, these
results suggest that decreased functional NMMIIA in the elderly
has a positive impact on the migration of CD41 T cells. Because
complete inhibition of NMMIIA negatively impacts chemotaxis
towards hSDF-1a, we believe that the increased migration observed
in the elderly may be suggestive of differential complexes recruited by
functional and non-functional NMMIIA in CD41 T-cell migration.
Additionally, as previous studies in other cell types have demonstrated
both an increase and a decrease in migration of cells upon blebbistatin
treatment,42 it is clear that graded NMMIIA levels may regulate migra-
tion, with partial versus complete inhibition impacting migration dif-
ferentially. Future studies will dissect the precise role of NMMIIA in
T-cell migration during aging.
DISCUSSION
In this study, we present evidence suggesting a novel role for NMMIIA
in T-cell functional deficits observed during aging in humans.
Previous reports from our laboratory and those of others have shown
that CD41 T cells from healthy elderly human subjects and aged mice
exhibit multiple defects in signal transduction events following TCR
ligation.12 These include alterations in tyrosine phosphorylation of
TCR-associated f-chains,43 calcium release from intracellular stores,
polymerization of F-actin11 and induction of nuclear translocation of
transcription factors.3,4 As dynamic properties of CD41 T cells, such
as migration, adhesion and cell division, depend on actin polymeriza-
tion andNMMIIA-dependent compression and retraction, alterations
in the activation status of NMMIAwill likely have profound effects not
only on migration and adhesion but also on CD41 T-cell antigen
receptor microcluster formation and immunological synapse stabil-
ization. Our data demonstrate a central role for NMMIIA dysregula-
tion in age-associated functional defects observed in CD41 T cells.
These defects range from alterations in actin polymerization and TCR
internalization to T-cell migration toward chemotactic gradients.
NMMIIA, which is abundantly associated with Hsp90, is constitu-
tively activated by phosphorylation of RLC in CD41 T cells obtained
from elderly donors. This basal phosphorylation of RLCmight explain
the inability of these cells to undergo any further stimulation upon
treatment with common polyclonal T-cell activators. Interestingly,
we now provide evidence that pre-treatment of CD41 T cells from
young donors with an NMMIIA-specific inhibitor, blebbistatin, alters
NMMIIA distribution in these cells and partially induces phosphor-
ylation of RLC, mimicking the observation in T cells from the elderly.
Taken together, these results suggest that inhibition of NMMIIA may
contribute to immune dysfunction in the elderly.
The dynamics of TCR downmodulation can directly impinge not only
on the termination of TCR signaling and T-cell activation but also on
events dictated by coreceptors such as cytotoxic T lymphocyte-associated
antigen 4 and programmed death-1.13,44,45 As several studies have now
attributed the decrease in the number of TCR on the cell surface to a
combination of processes involving internalization, recycling and degra-
dation, our studies for the first time show the requirement and involve-
ment of functional NMMIIA in activation-induced TCR internalization.
Additionally, we show that the functional inhibition of NMMIIA in
CD41 T cells from young donors results in an almost complete abroga-
tion of the TCR internalization induced by anti-CD3 antibody. This
block in TCR internalization is similar to that observed upon anti-CD3
treatment in CD41 T cells from the elderly, which implicates altered
NMMIIA in defective TCR internalization in the elderly.
The ubiquitin ligases, c-Cbl and Cbl-b, play essential roles in the
dynamics of TCR downmodulation by regulating vesicle sorting and
endosome-to-lysosome trafficking.44–47 Future studies will be directed
at delineating c-Cbl and Cbl-b status in T cells from the elderly.
Contrary to our expectations, defects inNMMIIA function inT cells
from the elderly did not drastically impair chemotactic migration
Figure 9 Activation-induced intracellular calcium flux decreased in CD41 T cells
from elderly donors. (a) Microfluorescent imaging of intracellular calcium flux in
CD41T cells obtained fromone representative young donor. (b)Microfluorescent
imaging of intracellular calcium flux in CD41 T cells obtained from a represent-
ative elderly donor. CD41 T cells from both young and elderly donors were either
pre-treated with blebbistatin or vehicle control, then incubated with Raji cells
pulsed with SEA. Ionomycin was used as a positive control. (c) Mean intracellular
concentrations of calcium6s.e. from six independent experiments are pre-
sented. ** denotes statistical significance at P,0.001. SEA, Staphylococcus
enterotoxin A.
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towards SDF-1a. In fact, CD41 T cells from the elderly demonstrated
a significant increase in migration index when compared to T cells
obtained from young donors. This increased migration toward SDF-1
supports data obtained in murine splenocytes and is indicative of a
reciprocal regulation of NMMIIA and chemotactic activity. As treat-
ment of both CD41 T cells from young and elderly donors with
blebbistatin completely abrogated chemotactic migration, we believe
that complete inhibition of functional activity of NMMIIA interferes
with and abrogates migration in CD41 T cells from both young and
elderly donors. This seemingly paradoxical observation of increased
chemotactic migration in CD41 T cells from the elderly in the context
of altered NMMIIA levels may be attributable to a partial but not
complete loss of NMMIIA activity in the elderly. Future studies
employing graded amounts of NMMIIA may be able to resolve the
magnitudes of response to chemokines and the expression of func-
tional NMMIIA. In fact, studies in adherent cells have demonstrated
either a reduction or an enhancement in migration upon myosin IIA
inhibition. Additionally, alteration in CXCR4 expression (previously
reported to be increased), actomyosin complex formation and F-actin
polymerization in CD41 T cells from the elderly may well have con-
tributed to the overall increase in migration observed in the elderly. As
CXCR4 expression on the surface of T cells is regulated by NMMIIA,
changes in functional NMMIIA in CD41 T cells from the elderly may
indirectly regulate chemotactic migration.
Overall, our findings have uncovered an important contribution of
NMMIIA to T-cell functional responses during immune senescence,
ranging from its role in activation-mediated TCR internalization to
intracellular calcium mobilization to chemotactic migration.
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